Pleasanton, CA, United States of America

Ernest Heflin

USPTO Granted Patents = 13 

 

Average Co-Inventor Count = 4.6

ph-index = 6

Forward Citations = 295(Granted Patents)


Location History:

  • Pleasanton, CA (US) (2012 - 2022)
  • San Ramon, CA (US) (2020 - 2024)

Company Filing History:


Years Active: 2012-2024

Loading Chart...
Loading Chart...
13 patents (USPTO):Explore Patents

Title: Innovations by Ernest Heflin in Cardiac Treatment

Introduction

Ernest Heflin is a notable inventor based in Pleasanton, CA, who has made significant contributions to the field of medical devices, particularly in the treatment of cardiac conditions. With a total of 13 patents to his name, Heflin's work focuses on innovative solutions for congestive heart failure and other related ailments.

Latest Patents

One of Heflin's latest patents is for heart anchor positioning devices, methods, and systems designed for the treatment of congestive heart failure. This invention includes a heart anchor tensioning device that features a main body and an elongate shaft. A tension member or tether can be inserted through a lumen of the elongate shaft, allowing the shaft to be advanced over the tension member within a body while the main body remains outside. The device also incorporates an anchor coupling mechanism that engages a heart anchor, moving it into contact with the heart's wall. This mechanism locks the heart anchor to prevent proximal movement along the tension member. Additionally, a tension indicating mechanism provides feedback on the force applied to the heart anchor.

Another significant patent involves medical devices, systems, and methods aimed at reducing the distance between two points in cardiac tissue. This approach is often utilized in minimally invasive procedures for treating congestive heart failure. An anchor is inserted through the heart's wall, and its arm is deployed and positioned for optimal alignment. By applying tension to the anchor, the first and second walls of the heart can be drawn into contact, facilitating a desired change in the heart's geometry. This method allows for the insertion of additional anchors to geometrically remodel the ventricle, potentially reversing or halting disease progression.

Career Highlights

Heflin has worked with several prominent companies in the medical device industry, including Bioventrix, Inc. and Volcano Corporation. His experience in these organizations has contributed to his expertise in developing innovative cardiac treatment solutions.

Collaborations

Some of Heflin's notable coworkers include Lon S Annest and Claudio Argento, who have collaborated with him on various projects in the medical field.

Conclusion

Ernest Heflin's contributions to cardiac treatment through his innovative patents demonstrate his commitment to improving patient outcomes. His work continues to influence the development of medical devices aimed at addressing complex heart conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…